Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
The Journal of Urology
|
August 1, 2019
Reply by Authors
Michael D Gross, Art Sedrakyan, Fernando J Bianco, et al.
British Journal of Neurosurgery
|
March 10, 2025
Monitoring of microsurgically and endovascularly treated aneurysms (META): protocol for an international multicentre retrospective cohort study
Cathal John Hannan, Jack Henry, David Brennan, et al.
Annals of the Rheumatic Diseases
|
September 23, 2020
Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma
Elena Pontarini, William James Murray-Brown, Cristina Croia, et al.
Swiss Medical Weekly
|
February 15, 2018
Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry
Alexandre Dumusc, Wan-Fai Ng, Katherine James, et al.
The Journal of Urology
|
January 9, 2018
Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies
Ron Golan, Adrien Bernstein, Art Sedrakyan, et al.
BMJ Surgery, Interventions, & Health Technologies
|
November 17, 2022
Advancing the Real-World Evidence for Medical Devices through Coordinated Registry Networks
Art Sedrakyan, Danica Marinac-Dabic, Bruce Campbell, et al.
Journal of Medicinal Chemistry
|
July 15, 2016
Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)
Felix Gonzalez-Lopez de Turiso, Xiaolin Hao, Youngsook Shin, et al.
Journal of Medicinal Chemistry
|
January 25, 2014
Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development
Daqing Sun, Zhihong Li, Yosup Rew, et al.
Journal of Medicinal Chemistry
|
March 20, 2014
Discovery of AMG 925, a FLT3 and CDK4 dual kinase inhibitor with preferential affinity for the activated state of FLT3
Zhihong Li, Xianghong Wang, John Eksterowicz, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
The Journal of Urology
|
August 1, 2019
Reply by Authors
Michael D Gross, Art Sedrakyan, Fernando J Bianco, et al.
British Journal of Neurosurgery
|
March 10, 2025
Monitoring of microsurgically and endovascularly treated aneurysms (META): protocol for an international multicentre retrospective cohort study
Cathal John Hannan, Jack Henry, David Brennan, et al.
Annals of the Rheumatic Diseases
|
September 23, 2020
Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma
Elena Pontarini, William James Murray-Brown, Cristina Croia, et al.
Swiss Medical Weekly
|
February 15, 2018
Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry
Alexandre Dumusc, Wan-Fai Ng, Katherine James, et al.
The Journal of Urology
|
January 9, 2018
Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies
Ron Golan, Adrien Bernstein, Art Sedrakyan, et al.
BMJ Surgery, Interventions, & Health Technologies
|
November 17, 2022
Advancing the Real-World Evidence for Medical Devices through Coordinated Registry Networks
Art Sedrakyan, Danica Marinac-Dabic, Bruce Campbell, et al.
Journal of Medicinal Chemistry
|
July 15, 2016
Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)
Felix Gonzalez-Lopez de Turiso, Xiaolin Hao, Youngsook Shin, et al.
Journal of Medicinal Chemistry
|
January 25, 2014
Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development
Daqing Sun, Zhihong Li, Yosup Rew, et al.
Journal of Medicinal Chemistry
|
March 20, 2014
Discovery of AMG 925, a FLT3 and CDK4 dual kinase inhibitor with preferential affinity for the activated state of FLT3
Zhihong Li, Xianghong Wang, John Eksterowicz, et al.
Page
of 5